AG
IDXX icon

Ascent Group’s Idexx Laboratories IDXX Stock Holding History

Ascent Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$407K Buy
774
+165
+27% +$92.5K 0.01% 585
2026
Q1 		$342K Sell
609
-112
-16% -$71.8K 0.01% 585
2025
Q4 		$488K Buy
721
+89
+14% +$60.6K 0.02% 499
2025
Q3 		$404K Buy
632
+18
+3% +$10.9K 0.01% 538
2025
Q2 		$329K Sell
614
-103
-14% -$49.3K 0.01% 560
2025
Q1 		$301K Buy
+717
New +$311K 0.01% 559
2022
Q3 		– Sell
-615
Closed -$245K – 482
2022
Q2 		$245K Sell
615
-147
-19% -$59.9K 0.03% 423
2022
Q1 		$417K Buy
762
+226
+42% +$119K 0.05% 349
2021
Q4 		$269K Buy
+536
New +$336K 0.03% 392

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Ascent Group's IDXX Position: Q2 2026 in Review

Ascent Group increased its Idexx Laboratories (IDXX) stake by 27% in Q2 2026, buying an estimated $92.5K and bringing the position to 774 shares worth $407K. The position accounts for 0.01% of the portfolio, ranked #585.

Ascent Group first reported a position in IDXX in Q4 2021 and has held it in 9 quarters since. The position peaked at $488K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Ascent Group held 774 shares of Idexx Laboratories worth $407K as of Q2 2026.
  • Ascent Group bought 165 Idexx Laboratories shares in Q2 2026, an estimated $92.5K.
  • Idexx Laboratories made up 0.01% of Ascent Group's portfolio in Q2 2026, its #585 holding.
  • Ascent Group first reported a position in Idexx Laboratories in Q4 2021 and has held it in 9 quarters since.
  • Ascent Group's Idexx Laboratories position peaked at $488K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.